img

Nuclear Medicine Therapeutics


Published on: 2024-01-04 | No of Pages : 154 | Industry : Pharma & Healthcare

Publisher : MRA Reports | Format : PDF&Excel

Nuclear Medicine Therapeutics

The global Nuclear Medicine Therapeutics market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on MRA Reports newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

IBA Group

Lantheus Medical Imaging

Triad Isotopes

Siemens Healthcare (PETNET Solutions)

NTP Radioisotopes



By Types

Alpha Emitters

Beta Emitters

Brachytherapy



By Applications

Application I

Application II



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Nuclear Medicine Therapeutics Revenue

1.5 Market Analysis by Type

1.5.1 Global Nuclear Medicine Therapeutics Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Alpha Emitters

1.5.3 Beta Emitters

1.5.4 Brachytherapy

1.6 Market by Application

1.6.1 Global Nuclear Medicine Therapeutics Market Share by Application: 2022-2027

1.6.2 Application I

1.6.3 Application II

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Nuclear Medicine Therapeutics Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Nuclear Medicine Therapeutics Market Players Profiles

3.1 IBA Group

3.1.1 IBA Group Company Profile

3.1.2 IBA Group Nuclear Medicine Therapeutics Product Specification

3.1.3 IBA Group Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Lantheus Medical Imaging

3.2.1 Lantheus Medical Imaging Company Profile

3.2.2 Lantheus Medical Imaging Nuclear Medicine Therapeutics Product Specification

3.2.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Triad Isotopes

3.3.1 Triad Isotopes Company Profile

3.3.2 Triad Isotopes Nuclear Medicine Therapeutics Product Specification

3.3.3 Triad Isotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Siemens Healthcare (PETNET Solutions)

3.4.1 Siemens Healthcare (PETNET Solutions) Company Profile

3.4.2 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product Specification

3.4.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 NTP Radioisotopes

3.5.1 NTP Radioisotopes Company Profile

3.5.2 NTP Radioisotopes Nuclear Medicine Therapeutics Product Specification

3.5.3 NTP Radioisotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Nuclear Medicine Therapeutics Market Competition by Market Players

4.1 Global Nuclear Medicine Therapeutics Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Nuclear Medicine Therapeutics Revenue Market Share by Market Players (2016-2021)

4.3 Global Nuclear Medicine Therapeutics Average Price by Market Players (2016-2021)

5 Global Nuclear Medicine Therapeutics Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Nuclear Medicine Therapeutics Market Size (2016-2021)

5.1.2 Nuclear Medicine Therapeutics Key Players in North America (2016-2021)

5.1.3 North America Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.1.4 North America Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Nuclear Medicine Therapeutics Market Size (2016-2021)

5.2.2 Nuclear Medicine Therapeutics Key Players in East Asia (2016-2021)

5.2.3 East Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.2.4 East Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Nuclear Medicine Therapeutics Market Size (2016-2021)

5.3.2 Nuclear Medicine Therapeutics Key Players in Europe (2016-2021)

5.3.3 Europe Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.3.4 Europe Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Nuclear Medicine Therapeutics Market Size (2016-2021)

5.4.2 Nuclear Medicine Therapeutics Key Players in South Asia (2016-2021)

5.4.3 South Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.4.4 South Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Nuclear Medicine Therapeutics Market Size (2016-2021)

5.5.2 Nuclear Medicine Therapeutics Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.5.4 Southeast Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Nuclear Medicine Therapeutics Market Size (2016-2021)

5.6.2 Nuclear Medicine Therapeutics Key Players in Middle East (2016-2021)

5.6.3 Middle East Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.6.4 Middle East Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Nuclear Medicine Therapeutics Market Size (2016-2021)

5.7.2 Nuclear Medicine Therapeutics Key Players in Africa (2016-2021)

5.7.3 Africa Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.7.4 Africa Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Nuclear Medicine Therapeutics Market Size (2016-2021)

5.8.2 Nuclear Medicine Therapeutics Key Players in Oceania (2016-2021)

5.8.3 Oceania Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.8.4 Oceania Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Nuclear Medicine Therapeutics Market Size (2016-2021)

5.9.2 Nuclear Medicine Therapeutics Key Players in South America (2016-2021)

5.9.3 South America Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.9.4 South America Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Nuclear Medicine Therapeutics Market Size (2016-2021)

5.10.2 Nuclear Medicine Therapeutics Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Nuclear Medicine Therapeutics Market Size by Type (2016-2021)

5.10.4 Rest of the World Nuclear Medicine Therapeutics Market Size by Application (2016-2021)

6 Global Nuclear Medicine Therapeutics Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Nuclear Medicine Therapeutics Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Nuclear Medicine Therapeutics Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Nuclear Medicine Therapeutics Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Nuclear Medicine Therapeutics Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Nuclear Medicine Therapeutics Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Nuclear Medicine Therapeutics Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Nuclear Medicine Therapeutics Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Nuclear Medicine Therapeutics Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Nuclear Medicine Therapeutics Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Nuclear Medicine Therapeutics Consumption by Countries

7 Global Nuclear Medicine Therapeutics Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Nuclear Medicine Therapeutics (2022-2027)

7.2 Global Forecasted Revenue of Nuclear Medicine Therapeutics (2022-2027)

7.3 Global Forecasted Price of Nuclear Medicine Therapeutics (2022-2027)

7.4 Global Forecasted Production of Nuclear Medicine Therapeutics by Region (2022-2027)

7.4.1 North America Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.3 Europe Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.7 Africa Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.9 South America Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Nuclear Medicine Therapeutics Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Nuclear Medicine Therapeutics by Application (2022-2027)

8 Global Nuclear Medicine Therapeutics Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.2 East Asia Market Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.3 Europe Market Forecasted Consumption of Nuclear Medicine Therapeutics by Countriy

8.4 South Asia Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.5 Southeast Asia Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.6 Middle East Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.7 Africa Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.8 Oceania Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.9 South America Forecasted Consumption of Nuclear Medicine Therapeutics by Country

8.10 Rest of the world Forecasted Consumption of Nuclear Medicine Therapeutics by Country

9 Global Nuclear Medicine Therapeutics Sales by Type (2016-2027)

9.1 Global Nuclear Medicine Therapeutics Historic Market Size by Type (2016-2021)

9.2 Global Nuclear Medicine Therapeutics Forecasted Market Size by Type (2022-2027)

10 Global Nuclear Medicine Therapeutics Consumption by Application (2016-2027)

10.1 Global Nuclear Medicine Therapeutics Historic Market Size by Application (2016-2021)

10.2 Global Nuclear Medicine Therapeutics Forecasted Market Size by Application (2022-2027)

11 Global Nuclear Medicine Therapeutics Manufacturing Cost Analysis

11.1 Nuclear Medicine Therapeutics Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Nuclear Medicine Therapeutics

12 Global Nuclear Medicine Therapeutics Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Nuclear Medicine Therapeutics Distributors List

12.3 Nuclear Medicine Therapeutics Customers

12.4 Nuclear Medicine Therapeutics Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Nuclear Medicine Therapeutics Revenue (US$ Million) 2016-2021

Table 6. Global Nuclear Medicine Therapeutics Market Size by Type (US$ Million): 2022-2027

Table 7. Alpha Emitters Features

Table 8. Beta Emitters Features

Table 9. Brachytherapy Features

Table 16. Global Nuclear Medicine Therapeutics Market Size by Application (US$ Million): 2022-2027

Table 17. Application I Case Studies

Table 18. Application II Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Nuclear Medicine Therapeutics Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Nuclear Medicine Therapeutics Market Growth Strategy

Table 46. Nuclear Medicine Therapeutics SWOT Analysis

Table 47. IBA Group Nuclear Medicine Therapeutics Product Specification

Table 48. IBA Group Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Lantheus Medical Imaging Nuclear Medicine Therapeutics Product Specification

Table 50. Lantheus Medical Imaging Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Triad Isotopes Nuclear Medicine Therapeutics Product Specification

Table 52. Triad Isotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Product Specification

Table 54. Table Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. NTP Radioisotopes Nuclear Medicine Therapeutics Product Specification

Table 56. NTP Radioisotopes Nuclear Medicine Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Nuclear Medicine Therapeutics Production Capacity by Market Players

Table 148. Global Nuclear Medicine Therapeutics Production by Market Players (2016-2021)

Table 149. Global Nuclear Medicine Therapeutics Production Market Share by Market Players (2016-2021)

Table 150. Global Nuclear Medicine Therapeutics Revenue by Market Players (2016-2021)

Table 151. Global Nuclear Medicine Therapeutics Revenue Share by Market Players (2016-2021)

Table 152. Global Market Nuclear Medicine Therapeutics Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 155. North America Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 157. North America Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 159. East Asia Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 162. East Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 164. East Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 166. Europe Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 169. Europe Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 171. Europe Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 173. South Asia Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 176. South Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 178. South Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 180. Southeast Asia Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 183. Southeast Asia Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 185. Southeast Asia Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 187. Middle East Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 190. Middle East Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 192. Middle East Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 194. Africa Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 197. Africa Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 199. Africa Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 201. Oceania Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 204. Oceania Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 206. Oceania Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 208. South America Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 211. South America Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 213. South America Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 215. Rest of the World Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Nuclear Medicine Therapeutics Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Nuclear Medicine Therapeutics Market Share (2016-2021)

Table 218. Rest of the World Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Nuclear Medicine Therapeutics Market Share by Type (2016-2021)

Table 220. Rest of the World Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Nuclear Medicine Therapeutics Market Share by Application (2016-2021)

Table 222. North America Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 223. East Asia Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 224. Europe Nuclear Medicine Therapeutics Consumption by Region (2016-2021)

Table 225. South Asia Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 226. Southeast Asia Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 227. Middle East Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 228. Africa Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 229. Oceania Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 230. South America Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 231. Rest of the World Nuclear Medicine Therapeutics Consumption by Countries (2016-2021)

Table 232. Global Nuclear Medicine Therapeutics Production Forecast by Region (2022-2027)

Table 233. Global Nuclear Medicine Therapeutics Sales Volume Forecast by Type (2022-2027)

Table 234. Global Nuclear Medicine Therapeutics Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Nuclear Medicine Therapeutics Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Nuclear Medicine Therapeutics Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Nuclear Medicine Therapeutics Sales Price Forecast by Type (2022-2027)

Table 238. Global Nuclear Medicine Therapeutics Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Nuclear Medicine Therapeutics Consumption Value Forecast by Application (2022-2027)

Table 240. North America Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 241. East Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 242. Europe Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 243. South Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 245. Middle East Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 246. Africa Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 247. Oceania Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 248. South America Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Nuclear Medicine Therapeutics Consumption Forecast 2022-2027 by Country

Table 250. Global Nuclear Medicine Therapeutics Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Nuclear Medicine Therapeutics Revenue Market Share by Type (2016-2021)

Table 252. Global Nuclear Medicine Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Nuclear Medicine Therapeutics Revenue Market Share by Type (2022-2027)

Table 254. Global Nuclear Medicine Therapeutics Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Nuclear Medicine Therapeutics Revenue Market Share by Application (2016-2021)

Table 256. Global Nuclear Medicine Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Nuclear Medicine Therapeutics Revenue Market Share by Application (2022-2027)

Table 258. Nuclear Medicine Therapeutics Distributors List

Table 259. Nuclear Medicine Therapeutics Customers List





Figure 1. Product Figure

Figure 2. Global Nuclear Medicine Therapeutics Market Share by Type: 2021 VS 2027

Figure 3. Global Nuclear Medicine Therapeutics Market Share by Application: 2021 VS 2027

Figure 4. North America Nuclear Medicine Therapeutics Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 6. North America Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 7. United States Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 8. Canada Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 12. China Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 13. Japan Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 15. Europe Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 16. Europe Nuclear Medicine Therapeutics Consumption Market Share by Region in 2021

Figure 17. Germany Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 19. France Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 20. Italy Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 21. Russia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 22. Spain Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 25. Poland Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 27. South Asia Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 28. India Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 30. Southeast Asia Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 31. Indonesia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 37. Middle East Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 38. Turkey Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 40. Iran Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 42. Africa Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 43. Africa Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 44. Nigeria Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 47. Oceania Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 48. Australia Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 49. South America Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 50. South America Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 51. Brazil Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Nuclear Medicine Therapeutics Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Nuclear Medicine Therapeutics Consumption and Growth Rate

Figure 54. Rest of the World Nuclear Medicine Therapeutics Consumption Market Share by Countries in 2021

Figure 55. Global Nuclear Medicine Therapeutics Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Nuclear Medicine Therapeutics Price and Trend Forecast (2022-2027)

Figure 58. North America Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 59. North America Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 75. South America Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Nuclear Medicine Therapeutics Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Nuclear Medicine Therapeutics Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 79. East Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 80. Europe Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 81. South Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 82. Southeast Asia Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 83. Middle East Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 84. Africa Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 85. Oceania Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 86. South America Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 87. Rest of the world Nuclear Medicine Therapeutics Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Nuclear Medicine Therapeutics

Figure 89. Manufacturing Process Analysis of Nuclear Medicine Therapeutics

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Nuclear Medicine Therapeutics Supply Chain Analysis